Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis

Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis

A combination of transarterial chemoembolization (TACE) plus sorafenib or radiotherapy (RT) has demonstrated efficacy in patients with advanced hepatocellular carcinoma (HCC). Here, the two combined treatment approaches were compared in patients with HCC and portal vein tumor thrombus (PVTT). Data f...

Full description

Bibliographic Details
Main Authors: Hee Ho Chu, Jin Hyoung Kim, Ju Hyun Shim, Sang Min Yoon, Pyeong Hwa Kim, Ibrahim Alrashidi
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
hepatocellular carcinoma
portal vein tumor thrombosis
transarterial chemoembolization
sorafenib
radiotherapy
Online Access:https://www.mdpi.com/2072-6694/12/5/1116

Similar Items

Similar Items